Duck Enteritis Virus Glycoprotein D and B DNA Vaccines Induce Immune Responses and Immunoprotection in Pekin Ducks

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zhao, Yan ^a,b   Cao, Yongsheng ^b   Cui, Lihong ^b   Ma, Bo ^b   Mu, Xiaoyu ^b   Li, Yanwei ^b   Zhang, Zhihui ^b   Li, Dan ^b   Wei, Wei ^b   Gao, Mingchun ^b   Wang, Junwei ^b  

^a Harbin Veterinary Research Institute   (China)

^b NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GLYCOPROTEIN B; GLYCOPROTEIN D; NEUTRALIZING ANTIBODY; PLASMID DNA; IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BIRD DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DUCK; DUCK VIRUS ENTERITIS; EMBRYO; HUMORAL IMMUNITY; INFECTION PREVENTION; INFECTION RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; ANTIBODY TITER; CELL LINE; DF1 CELL LINE; DNA VIRUS INFECTION; DRUG EFFICACY; DUCK ENTERITIS VIRUS INFECTION; GENETIC TRANSFECTION; IMMUNOMODULATION; IMMUNOSTIMULATION; MORTALITY; PEKIN DUCK; VACCINATION; VIRUS VIRULENCE; ANIMAL; GENETICS; IMMUNOLOGY; MARDIVIRUS; POULTRY DISEASES;

ANIMALS; ANTIBODIES, VIRAL; DUCKS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; MARDIVIRUS; POULTRY DISEASES; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 84899692044     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095093.t001     Document Type: Article

References (38)

1. Davison S, Converse KA, Hamir AN, Eckroade RJ (1993) Duck viral enteritis in domestic muscovy ducks in Pennsylvania. Avian Dis 37: 1142-1146. (Pubitemid 2037972)
2. Baudet AERF (1923) Mortality in ducks in the Netherlands caused by a filtrable virus; fowl plague. Tijdschr Diergeneeskd 50: 5.
3. Huang YX (1959) Study on duck plague-like disease. South China Agricultural University journal 1: 12.
4. Burgess EC, Ossa J, Yuill TM (1979) Duck plague: a carrier state in waterfowl. Avian Dis 23: 940-949.
5. King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (2012) Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, San Diego: 1344.
6. Highlander SL, Sutherland SL, Gage PJ, Johnson DC, Levine M, et al. (1987) Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol 61: 3356-3364. (Pubitemid 17152156)
7. Fuller AO, Spear PG (1987) Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface. Proc Natl Acad Sci U S A 84: 5454-5458.
8. Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, et al. (1999) Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA 282: 331-340. (Pubitemid 29350487)
9. Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, et al. (2002) Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 347: 1652-1661. (Pubitemid 35340783)
10. Long D, Madara TJ, Ponce de Leon M, Cohen GH, Montgomery PC, et al. (1984) Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infect Immun 43: 761-764. (Pubitemid 14176643)
11. Landolfi V, Zarley CD, Abramovitz AS, Figueroa N, Wu SL, et al. (1993) Baculovirus-expressed herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge. Vaccine 11: 407-414. (Pubitemid 23083463)
12. Mishkin EM, Fahey JR, Kino Y, Klein RJ, Abramovitz AS, et al. (1991) Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models. Vaccine 9: 147-153.
13. Byrne KM, Horohov DW, Kousoulas KG (1995) Glycoprotein B of bovine herpesvirus-1 binds heparin. Virology 209: 230-235.
14. Li Y, van Drunen Littel-van den Hurk S, Liang X, Babiuk LA (1997) Functional analysis of the transmembrane anchor region of bovine herpesvirus 1 glycoprotein gB. Virology 228: 39-54. (Pubitemid 27238818)
15. Kuhn JE, Kramer MD, Willenbacher W, Wieland U, Lorentzen EU, et al. (1990) Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface. J Virol 64: 2491-2497. (Pubitemid 20171232)
16. Miethke A, Keil GM, Weiland F, Mettenleiter TC (1995) Unidirectional complementation between glycoprotein B homologues of pseudorabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule. J Gen Virol 76 (Pt 7): 1623-1635.
17. Cantin EM, Eberle R, Baldick JL, Moss B, Willey DE, et al. (1987) Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc Natl Acad Sci U S A 84: 5908-5912.
18. Cranage MP, Kouzarides T, Bankier AT, Satchwell S, Weston K, et al. (1986) Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J 5: 3057-3063.
19. Fitzpatrick DR, Zamb T, Parker MD, van Drunen Littel-van den Hurk S, Babiuk LA, et al. (1988) Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells. J Virol 62: 4239-4248.
20. Guo PX, Goebel S, Perkus ME, Taylor J, Norton E, et al. (1990) Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity. J Virol 64: 2399-2406. (Pubitemid 20148491)
21. Ikuta K, Ueda S, Kato S, Hirai K (1984) Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization. J Virol 49: 1014-1017. (Pubitemid 14191117)
22. Ikuta K, Ueda S, Kato S, Hirai K (1984) Processing of glycoprotein gB related to neutralization of Marek's disease virus and herpesvirus of turkeys. Microbiol Immunol 28: 923-933. (Pubitemid 14030259)
23. Keller PM, Neff BJ, Ellis RW (1984) Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J Virol 52: 293-297. (Pubitemid 14000501)
24. Niikura M, Matsuura Y, Endoh D, Onuma M, Mikami T (1992) Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV. J Virol 66: 2631-2638.
25. Lennette EH, Lennette DA, Lennette ET (1995) Diagnosis procedure for viral, rickettsial and chlamydial infections, 7th ed. American Public Health Association, Washington, DC.
26. Babiuk LA, L'Italien J, van Drunen Littel-van den Hurk S, Zamb T, Lawman JP, et al. (1987) Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology 159: 57-66.
27. Israel BA, Herber R, Gao Y, Letchworth GJ, 3rd (1992) Induction of a mucosal barrier to bovine herpesvirus 1 replication in cattle. Virology 188: 256-264.
28. Denis M, Slaoui M, Keil G, Babiuk LA, Ernst E, et al. (1993) Identification of different target glycoproteins for bovine herpes virus type 1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Immunology 78: 7-13. (Pubitemid 23035842)
29. van Drunen Littel-van den Hurk S, Parker MD, Massie B, van den Hurk JV, Harland R, et al. (1993) Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. 0264-410X (Print).
30. Oliveira SC, Harms JS, Rosinha GM, Rodarte RS, Rech EL, et al. (2000) Biolistic-mediated gene transfer using the bovine herpesvirus-1 glycoprotein D is an effective delivery system to induce neutralizing antibodies in its natural host. J Immunol Methods 245: 109-118.
31. van Drunen Littel-van den Hurk S, Gifford GA, Babiuk LA (1990) Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 8: 358-368.
32. Manservigi R, Grossi MP, Gualandri R, Balboni PG, Marchini A, et al. (1990) Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector. J Virol 64: 431-436. (Pubitemid 20032648)
33. Caselli E, Grandi P, Argnani R, Balboni PG, Selvatici R, et al. (2001) Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection. Intervirology 44: 1-7. (Pubitemid 32172937)
34. Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, et al. (2003) Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. J Infect Dis 187: 542-549. (Pubitemid 36250017)
35. Milligan GN, Bernstein DI, Bourne N (1998) T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol 160: 6093-6100. (Pubitemid 28298073)
36. Lian B, Cheng A, Wang M, Zhu D, Luo Q, et al. (2011) Induction of immune responses in ducks with a DNA vaccine encoding duck plague virus glycoprotein C. Virol J 8: 214.
37. Zhou FJ, Hu ZL, Dai JX, Chen RW, Shi K, et al. (2003) Protection of tree shrews by pVAX-PS DNA vaccine against HBV infection. DNA Cell Biol 22: 475-478. (Pubitemid 36981464)
38. Jin Y, Cao C, Li P, Liu X, Huang W, et al.(2005) Boosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid. Clin Diagn Lab Immunol 12: 1364-1369. (Pubitemid 41814205)